SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CEPH - CEPHALON

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: patron_anejo_por_favor who wrote (45)7/11/2003 6:28:59 PM
From: Icebrg  Read Replies (2) of 109
 

2002 2001 2000
--------- --------- ---------
Product sales:
PROVIGIL $ 196,265 $ 150,305 $ 72,089
ACTIQ 126,725 51,197 15,169
GABITRIL 48,760 24,630 4,379
Group Lafon products 94,193 — —
--------- --------- ---------
Total product sales 465,943 226,132 91,637
--------- --------- ---------
Other revenues:
H. Lundbeck A/S 10,411 11,941 10,395
Novartis Pharma AG 3,564 5,780 —
Sanofi-Synthlabo 20,899 5,052 —
Other 6,080 13,090 9,758
--------- --------- ---------
Total other revenues 40,954 35,863 20,153
--------- --------- ---------
Total revenues $ 506,897 $ 261,995 $ 111,790
--------- --------- ---------

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext